newsfilter
← Latest News
GlobeNewswire·

Cartesian Therapeutics Announces Presentation at the Upcoming 66th ASH Annual Meeting

FREDERICK, Md., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Cartesian Therapeutics, Inc. (NASDAQ:RNAC) (the "Company"), a clinical-stage biotechnology company pioneering mRNA cell therapy for autoimmune diseases, today announced